KalVista Pharmaceuticals (NASDAQ:KALV) Upgraded at Citizens Jmp
Citizens Jmp upgraded shares of KalVista Pharmaceuticals (NASDAQ:KALV – Free Report) to a strong-buy rating in a report ...
JMP Securities Reaffirms Their Buy Rating on Blueprint Medicines (BPMC)
JMP Securities analyst Reni Benjamin maintained a Buy rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of ...
Astria Therapeutics (NASDAQ:ATXS) Rating Increased to Strong-Buy at Citizens Jmp
Citizens Jmp upgraded shares of Astria Therapeutics (NASDAQ:ATXS – Free Report) to a strong-buy rating in a report published on Friday,Zacks.com reports. Other equities analysts have also recently ...
JMP Securities Sticks to Its Buy Rating for Protagonist Therapeutics (PTGX)
JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on Protagonist Therapeutics (PTGX – Research Report) today and set a price ...
Yahoo Finance29d
JMP Expects a ‘Value-Creating Year’ for These 2 High-Yield Dividend Stocks
Covering some solid dividend stocks for JMP, analyst Aaron Hecht sees a reason ... with a focus on the medical and health care industry. This company, Sabra Health Care, operates through the ...
JMP maintains Century Casinos stock at Market Outperform
JMP Securities maintained its Market Outperform rating on Century Casinos shares (NASDAQ:CNTY) with a set price target of $5.00. The firm highlighted Century Casinos' potential as an attractive merger ...